Clinical trial · Interventional
EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient
EMDR Psychotherapy of Anxious-depressive Symptoms for Women That Present an Invasive Beast Cancer : a Faisability Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will consist in an adjustment/adaptation of the "standard EMDR protocol" for cancer disease, and most particulary for women who present a breast cancer and during adjuvant therapy. It will also test the faisability of the research, with a view to adjust the calendar and the ressources to put at disposal for a randomized control trial that follow. This study will also allow to test the need and acceptibility of this new psychotherapy for the patient, and to identify facilitators and obstacles : participation/rejection ratio, inclusion rythm, adhesion of the medical staff about the project
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Eye Movement Desensitization and Processing | — | UNRESOLVED | — |
| Psychoterapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EMDR psychotherapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Arms
- description
- Experimental: EMDR psychotherapy All the women will be in this arm and thus will receive the same intervention which is : 8 sessions (1 per week). The first session is an inclusion visit at Metz-Thionville Hospital, then 6 EMDR psychotherapy sessions and finally a last visit one month after for data recovery (questionnaire and semi-directive interview)
- interventionNames
- Behavioral: EMDR psychotherapy
Primary outcomes (1)
- measure
- patients involvement
- timeFrame
- week 12
- description
- acceptability of the new psychotherapy
Secondary outcomes (2)
- measure
- adequacy of the intervention with the field
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Being a woman aged of 18 years or more * Having a primary invasive breast cancer * Having undergo a mastectomy for a primary invasive breast cancer * Being able to complete the questionnaires * Being informed of the study and having signed the informed consent * Being affiliated to a welfare system Exclusion Criteria: * having contraindications to recieve EMDR psychotherapy (neurologic disorders, dissociatif states, oculomotor issues) * Having started adjuvant treatments following surgery * Having metastatic breast cancer * Presenting physical polypathologies * Having psychiatric antecedents (included anxiety and depressif disorders - assessed with M.I.N.I. (Sheehan and al., 1997)). * Having drug or alcohol addiction * Being placed under the safeguard of justice, guardianship or trusteeship * Being pregnant or breast-feeding
References
Publications (1)
- RESULTTarquinio, C. , Machado, J. , Longo, R. , Siles, J. , Bruno, J. , Gendarme, S. , Ziegler, A. , Mellouki, N. , Eby, E. and Rotonda, C. (2022) The Treatment of Anxious-Depressive Disorders among Breast Cancer Patients Integrating the EMDR Psychotherapy: From Pilot Study Results to the Development of a Randomized Trial. Psychology, 13, 313-327. doi: 10.4236/psych.2022.133019.